Since 2005, Pfizer Inc. has eliminated more than 56,000 jobs world-wideâ€”a number roughly equal to the population of a large suburb. More job losses could be on the way. . Health-care companies have unveiled a flurry of mergers or hostile bids in recent days, topped by Pfizer's roughly $100 billion pursuit of U.K. competitor AstraZeneca PLC. Companies are taking advantage of their large cash reserves and rising stock prices to pursue takeovers. In Pfizer's case, the prospect of paying less tax by moving the company's official...
  